Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
NCT04830215
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
122
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Brexpiprazole
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators
[object Object]
[object Object]